156 related articles for article (PubMed ID: 38406957)
21. The role of mammalian target of rapamycin inhibitors in the management of post-transplant malignancy.
Klintmalm GB; Saab S; Hong JC; Nashan B
Clin Transplant; 2014 Jun; 28(6):635-48. PubMed ID: 24628264
[TBL] [Abstract][Full Text] [Related]
22. Skin cancer after renal transplantation: Results of a multicenter study in Iran.
Einollahi B; Nemati E; Lessan-Pezeshki M; Simforoosh N; Nourbala MH; Rostami Z; Nafar M; Pourfarziani V; Beiraghdar F; Mahdavi-Mazdeh M; Ahmadpour P; Makhdoomi K; Ghafari A; Ardalan MR; Taebi Khosroshahi H; Oliaei F; Shahidi S; Makhlogh A; Azmandian J; Samimagham HR; Shabazian H
Ann Transplant; 2010; 15(3):44-50. PubMed ID: 20877266
[TBL] [Abstract][Full Text] [Related]
23. Cancer after renal transplantation.
Vasudev B; Hariharan S
Curr Opin Nephrol Hypertens; 2007 Nov; 16(6):523-8. PubMed ID: 18089965
[TBL] [Abstract][Full Text] [Related]
24. Use of proliferation signal inhibitors in the management of post-transplant malignancies--clinical guidance.
Campistol JM; Albanell J; Arns W; Boletis I; Dantal J; de Fijter JW; Mortensen SA; Neumayer HH; Øyen O; Pascual J; Pohanka E; Schena FP; Serón D; Sparacino V; Chapman JR
Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i36-41. PubMed ID: 17456617
[TBL] [Abstract][Full Text] [Related]
25. [Early de novo neoplasia after renal transplantation].
Veroux P; Veroux M; Puliatti C; Amodeo C; Macarone M; Cappello D; Caglià P
Tumori; 2003; 89(4 Suppl):301-4. PubMed ID: 12903627
[TBL] [Abstract][Full Text] [Related]
26. Cancer incidence after immunosuppressive treatment following kidney transplantation.
Andrés A
Crit Rev Oncol Hematol; 2005 Oct; 56(1):71-85. PubMed ID: 15978827
[TBL] [Abstract][Full Text] [Related]
27. Malignancy after Solid Organ Transplantation: Comprehensive Imaging Review.
Katabathina VS; Menias CO; Tammisetti VS; Lubner MG; Kielar A; Shaaban A; Mansour J; Surabhi VR; Hara AK
Radiographics; 2016; 36(5):1390-407. PubMed ID: 27618321
[TBL] [Abstract][Full Text] [Related]
28. De Novo Malignant Neoplasms in Renal Transplant Patients.
Yılmaz Akçay E; Tepeoğlu M; Özdemir BH; Deniz E; Börcek P; Haberal M
Exp Clin Transplant; 2016 Nov; 14(Suppl 3):100-105. PubMed ID: 27805524
[TBL] [Abstract][Full Text] [Related]
29. Malignancies in renal transplantation: an unmet medical need.
Dantal J; Pohanka E
Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i4-10. PubMed ID: 17456618
[TBL] [Abstract][Full Text] [Related]
30. Renal cell cancer after kidney transplantation.
Kleine-Döpke D; Oelke M; Schwarz A; Schwager Y; Lehner F; Klempnauer J; Schrem H
Langenbecks Arch Surg; 2018 Aug; 403(5):631-641. PubMed ID: 30003323
[TBL] [Abstract][Full Text] [Related]
31. Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection.
Marcén R
Drugs; 2009 Nov; 69(16):2227-43. PubMed ID: 19852526
[TBL] [Abstract][Full Text] [Related]
32. Post-transplantation Malignancy After Kidney Transplantation in Turkey.
Keles Y; Tekin S; Duzenli M; Yuksel Y; Yücetin L; Dosemeci L; Sengul A; Demirbaş A; Tuncer M
Transplant Proc; 2015 Jun; 47(5):1418-20. PubMed ID: 26093732
[TBL] [Abstract][Full Text] [Related]
33. Minimizing the risk of posttransplant malignancy.
Campistol JM
Transplantation; 2009 Apr; 87(8 Suppl):S19-22. PubMed ID: 19384182
[TBL] [Abstract][Full Text] [Related]
34. Incidence and Risk Factors of Post-renal Transplantation Malignancies in North of Iran, A 20-year Experience.
Nejatifar F; Monfared A; Khosravi M; Lebadi M; Shakiba M; Mokhtari G; Aghajanzadeh P; Haghdar-Saheli Y; Movasaghi A; Ramezanzadeh E; Akhondzadeh L
Iran J Kidney Dis; 2020 Dec; 14(6):439-447. PubMed ID: 33277447
[TBL] [Abstract][Full Text] [Related]
35. [Neoplasms and kidney transplantation. Case contribution].
Capocasale E; Bignardi L; Adorni A; D'Errico G; Viola V; Botta GC
Minerva Urol Nefrol; 1998 Jun; 50(2):127-31. PubMed ID: 9707967
[TBL] [Abstract][Full Text] [Related]
36. Malignancies after pediatric kidney transplantation: more than PTLD?
Mynarek M; Hussein K; Kreipe HH; Maecker-Kolhoff B
Pediatr Nephrol; 2014 Sep; 29(9):1517-28. PubMed ID: 24061645
[TBL] [Abstract][Full Text] [Related]
37. [Infectious and neoplasic complications after kidney transplantation].
Mourad G; Serre JE; Alméras C; Basel O; Garrigue V; Pernin V; Le Quintrec M
Nephrol Ther; 2016 Nov; 12(6):468-487. PubMed ID: 27686031
[TBL] [Abstract][Full Text] [Related]
38. De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr.
Apel H; Walschburger-Zorn K; Häberle L; Wach S; Engehausen DG; Wullich B
Clin Transplant; 2013; 27(1):E30-6. PubMed ID: 23278453
[TBL] [Abstract][Full Text] [Related]
39. Malignancy after transplantation.
Buell JF; Gross TG; Woodle ES
Transplantation; 2005 Oct; 80(2 Suppl):S254-64. PubMed ID: 16251858
[TBL] [Abstract][Full Text] [Related]
40. [Malignant tumors following renal transplantation].
Végso G; Járay J
Orv Hetil; 2007 Nov; 148(45):2115-23. PubMed ID: 17984022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
